<?xml version="1.0" encoding="UTF-8"?>
<p>The drugs of choice at this stage are antimalarials, preferably hydroxychloroquine (HCQ). In this guideline, methotrexate (MTX) is an option for inflammatory joint disease (moderate or severe disease affecting more than 5 joints, moderate to severe edema and pain) and HCQ for less-severe forms. </p>
